BioSpace News Archive

Poolbeg Pharma announces that at the Annual General Meeting held at 11:00am today, all resolutions were duly passed with in excess of 99.9% approval.

Arch Therapeutics, Inc. today announced that two clinical case report abstracts of AC5 ® Advanced Wound System were accepted for Poster Presentations at the upcoming 2022 Symposium on Advanced Wound Care (SAWC) Spring.

Achilles Therapeutics plc announced that the Company will host a key opinion leader webcast to discuss the importance and unique utility of the TRACERx study in validating the identification of clonal neoantigens as targets for personalized T cell therapies and to highlight selections from the 31 posters and presentations on the TRACERx study presented at the 2022 American Association for Cancer Research Annual Meeting.

Selecta Biosciences, Inc. announced that Company’s Management will participate in a fireside chat and one-on-one investor meetings at the 21st Annual Needham Virtual Healthcare Conference, to be held virtually April 11-14, 2022.

Amedisys, Inc., a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of Evolution Health, LLC, a provider of home health services.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the acquisition of MD Orthopaedics, including its bracing product lines and the patented Mitchell Ponseti® Ankle-Foot Orthosis system for the treatment of clubfoot.

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), announced today that fifteen presentations highlighting the clinical and cost-savings benefits of the RECELL® Autologous Cell Harvesting Device (RECELL® System) for the treatment of burn wounds will be shared at the American Burn Association (ABA) Annual Meeting.

Nautilus Biotechnology, Inc. today announced presentations at the following leading scientific and medical conferences. XIV Annual Congress of the European Proteomics Association (EuPA).

Humacyte, Inc. announced that its 2022 annual meeting of shareholders will be held virtually on Thursday, June 9, 2022, at 7:30 AM eastern time.

Mustang Bio, Inc. today announced that members of Mustang’s management team will participate in the two-day Fortress Biotech (“Fortress”) Virtual R&D Summit taking place on Tuesday, April 5, 2022.